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Abstract
Although the long non-coding RNA (lncRNA) landscape is expanding rapidly, only a
small number of lncRNAs have been functionally annotated. Here, we present
decodeRNA (http://www.decoderna.org), a database providing functional contexts for
both human lncRNAs and microRNAs in 29 cancer and 12 normal tissue types. With
state-of-the-art data mining and visualization options, easy access to results and a




Recent technological advances have led to the notion that
over 80% of the human genome is pervasively transcribed,
dramatically increasing the complexity of the transcrip-
tome. In addition to miRNAs that have been the focus of
intense research over the last decade, a plethora of long
non-coding RNAs (lncRNAs) has been discovered. The lat-
est release of LNCipedia reports over 111 000 annotated
human lncRNA transcripts and that number is expected to
increase with future RNA sequencing efforts on various tis-
sue and cell types (1). However, whether all these RNA
molecules are truly non-coding and functional is still under
debate. Unlike miRNAs, lncRNAs primarily regulate gene
expression at the transcriptional level by binding and (re-
)positioning transcription factors or proteins involved in
the regulation of chromatin architecture. Although the
mechanisms of lncRNA function are starting to emerge,
the pathways and processes downstream of lncRNAs
largely remain elusive. This is further complicated by the
lack of lncRNA target prediction tools. Such tools are
available in the miRNA field and have dramatically accel-
erated our understanding of miRNA function.
Since functional validation has only been performed for
a handful of lncRNAs [184 human lncRNAs in lncrnadb
v2.0 (2)], several studies have successfully applied the
guilt-by-association principle to infer functions of
lncRNAs on a genome-wide scale (3–5). This approach is
based on a correlation analysis between matching non-
coding RNA and protein coding mRNA expression in com-
bination with enrichment strategies to project functional
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protein coding gene sets onto mRNAs correlated with the
ncRNA of interest (3,6). Previously, our lab published an
online database containing such inferred functions for
miRNAs called the miRNA body map (4). Similar web
tools utilizing enrichment strategies to predict miRNA
functions have been published following our original publi-
cation (7,8). To our knowledge, only two other web
tools—lncRNA2function (57 samples from 2 studies) and
co-LncRNA (29 012 samples from 241 independent data-
sets)—apply this method for lncRNAs. Both tools follow a
hypergeometric test-based approach—limited to co-
expressed genes—to identify lncRNA functionality. Other,
non-enrichment-based approaches to characterize lncRNA
functionality include e.g. transcription factor binding
(TF2LncRNA) (9), lncRNA/protein and lncRNA/DNA
binding (longTarget) (10), differential mRNA expression
upon lncRNA modulation (lncRNA2Target) (11) or a
combination of lncRNA expression, sequence conserva-
tion, coding potential and secondary structure formation
(lncRNAtor, lncRNA-MFDL) (12,13).
Here, we present decodeRNA, the successor of miRNA
body map. decodeRNA contains inferred functions both
for miRNAs and lncRNAs in over 29 cancer and 12 nor-
mal tissue types (10 489 samples in total) with novel visual-
ization, data analysis and data interpretation features.
Compared to other tools, decodeRNA enables users to
(i) retrieve ncRNA-pathway associations and miRNA-
target associations in individual datasets as well as across
all datasets, (ii) compare these associations between data-




Functional lncRNA and miRNA contexts in decodeRNA are
based on matching lncRNA, miRNA and mRNA expression
data from The Cancer Genome Atlas (TCGA). Processed
data are stored in a MySQL database optimized for conveni-
ent data retrieval. At the time of data retrieval, level 3 RNA-
seq and small RNA-seq data are available for 10 489 samples
representing 29 cancer and 12 normal tissue types. LncRNA
identifiers are associated with common gene names and
LNCipedia IDs, whereas miRNAs are linked to their official
miRBase entry. ncRNA functions are inferred using the
GSEA method as reported previously (4) with functional
gene set collections obtained from the Molecular Signatures
Database (14) including Chemical and Genetic Perturbations
(CGP), Pathway Interaction Database (PID) and the
BioCarta, KEGG and Reactome pathways. Currently, func-
tional contexts for miRNAs and lncRNAs are based on> 500
million datapoints for 3340 ncRNA genes (2320 lncRNAs
and 1020 miRNAs). In total, 98.81% of the lncRNAs and all
of the miRNAs present in the TCGA (small) RNA-seq data-
sets have at least one associated gene set, with an average of
60.41 and 58.15 ncRNA/geneset correlations per tissue type
for lncRNA and miRNA, respectively.
Workflow
Small RNA-seq datasets (level 3) were downloaded from
TCGA and miRNA read counts were normalized based on
total miRNA read counts as reported previously (15). For
RNA-seq data, normalized gene expression values (level 3)
were downloaded. Expression-correlation matrices
(Spearman’s rank) for each dataset were constructed by
combining lncRNA and miRNA expression data with
matching mRNA expression data. These matrices were
used as input for gene set enrichment analysis (in combin-
ation with the C2 curated gene set list obtained from
MSigDB) (14). For each highly confident ncRNA—gene
set association (GSEA FDR< 0.001), gene set FDR, gene
set enrichment score, leading-edge mRNAs (up to a max-
imum of 20 per gene set) and leading-edge mRNA correl-
ation values were stored in separate MySQL tables, based
on the type of gene set (CGP, KEGG, BioCarta, Reactome
or PID), and coupled to the relevant dataset. As we are
working with poly-A enriched RNA-seq data, decodeRNA
does not contain information for non-poly-adenylated
lncRNAs. For miRNA datasets, miRNA/mRNA target as-
sociations, retrieved from miRDB, are stored for inclusion
in downstream visualizations (Figure 1) (16).
Features
The interface allows easy retrieval of various information
layers. When using the lncRNA to tissue/gene set workflow
to identify potential lncRNA functions, users are guided to
the main ncRNA2function page upon the selection of the
desired RNA type (lncRNA or miRNA) and submission of
a ncRNA identifier. Here, depending on the molecule of
interest, two (for lncRNAs) or four (for miRNAs) types of
analysis are available. For both lncRNAs and miRNAs,
functional contexts (i.e. ncRNA—gene set associations) in
all or a selection of the registered datasets can be displayed.
The first option will display a form where the functional
context query can be customized. The gene set collection
and (up to five) datasets of interest can be selected and an
FDR cutoff can be set (relevant for further visualization
purposes). This enables users to further reduce the number
of resulting functional contexts to the most confident ones.
Output can be generated in the form of gene set lists with
associated FDR-values, a Circos plot displaying the gene
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sets and corresponding (up to 200) leading-edge genes
(defined as the core of a gene set that accounts for the en-
richment signal), or a customizable Circos plot enabling the
user to select the gene sets to be visualized (17). Edges con-
necting identical leading-edge genes in different gene sets
can be used to appreciate the degree of gene set overlap. All
data used to generate the list or Circos plots can be ex-
ported as tab-separated text files. Choosing the second op-
tion will show the user in what fraction of all available
datasets each gene set—correlated with the ncRNA of
interest—is present, ranked based on significance, with
link-outs to MsigDB for more information regarding the
corresponding gene set and the possibility to view FDR-
values and enrichment scores for a certain gene set in all of
the significant datasets. A second workflow allows users a
different entry into the decodeRNA data. Following the se-
lection of a tissue type of interest, lncRNAs associated with
at least one gene set (FDR¼ 0) in that tissue type are
retrieved. LncRNAs and their corresponding gene sets are
visualized in a list format, ranked according to the number
Figure 1. Schematic overview of the analysis workflow and the online repositories used (CGP¼ chemical and genetic perturbations, BRCA¼breast in-
vasive carcinoma, LUSC¼ lung squamous cell carcinoma).
Figure 2. Circos plot representing significant gene sets for the lncRNA HOTAIR in breast tumor tissue, focusing on the CGP gene set.
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of gene sets associated with each lncRNA. This allows users
to identify lncRNAs associated with specific cellular proc-
esses or lncRNAs having certain gene set association in
common, hinting at potential lncRNA functions.
For miRNAs, two additional analyses, related to the
targets of these miRNAs, are available. The first is across
all available datasets and displays a list of predicted
miRNA targets whose expression is negatively correlated
with the miRNA of interest (Spearman rho<0.5, P-val-
ue< 0.05), along with the fraction of datasets in which a
significant negative expression correlation is observed. The
second analysis uses a form to filter miRNA target results
according to dataset selection and level of significance.
Results are shown in either a list form or by means of a
Circos plot, with similar layout as the pathway-option
described above.
Generating hypotheses using decodeRNA
predictions
When focusing on highly significant gene set associations
(FDR¼ 0), the lncRNAs present in decodeRNA have an
average of 26.30 associations per dataset. A distribution
plot for the number of gene sets associated with each
Figure 3. Gene set list across all available datasets for lncRNA HOTAIR, ranked according to the fraction of datasets in which a significant association
(positive or negative) can be found: (1) gene set name with linkout to MsigDB, (2) number and (3) fraction of datasets in which a correlation with the
associated gene set can be found, (4) tissue name, (5) tissue type, (6) data source, (7) gene set false discovery rate and (8) gene set normalized enrich-
ment score; (KIRC¼ kidney renal clear cell carcinoma, COAD¼ colon adenocarcinoma, LIHC¼ liver hepatocellular carcinoma, THCA¼ thyroid carcin-
oma, CHOL¼ cholangiocarcinoma, KICH¼ kidney chromophobe, LUSC¼ lung squamous cell carcinoma, DLBC¼ lymphoid neoplasm diffuse large
B-cell lymphoma, HNSC¼head and neck squamous cell carcinoma, KIRP¼ kidney renal papillary cell carcinoma, BRCA¼breast invasive carcinoma).
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ncRNA across all datasets can be observed in
Supplementary Figure S1. For 26 lncRNAs, identical gene
set associations can be observed in all available tissue
types. Most of these gene sets correspond to global cellular
processes such as translation regulation, oxidative phos-
phorylation, electron transport and ATP synthesis, suggest-
ing these lncRNAs are involved in housekeeping functions,
common across tissue types. For three of these lncRNAs
(SNHG5, GAS5 and ZFAS1), such functions have indeed
been identified (18–20). Alternatively, we can subset the
database for more specific gene sets. For instance, when
searching for lncRNAs with putative involvement in the
MYC pathway, 2190 lncRNAs were identified with high
correlation (abs(NES) >¼ 0.7) to MYC associated gene
sets, including SNHG16, DANCR, USP2-AS1, DLEU2,
SNHG15, PVT1, CASC11, SNHG6 and VPS9D1-AS1
(21–26). In a similar way, lncRNAs linked to cell prolifer-
ation (n¼1684, including TMPO-AS1, DEPDC1-AS1,
HMMR-AS1, UHRF1, FAM83A-AS1, KDM4A-AS1,
DDX11-AS1 and DLEU2) or migration (n¼ 1335, includ-
ing DEPDC1-AS1, C14orf34, FAM83A-AS1 and HMMR-
AS1) can be identified (27–35). A full list of the lncRNAs
with the number of associated migration/proliferation/
MYC gene sets can be found in Supplementary Table S1.
Novel lncRNA—gene set predictions including several
ones in Supplementary Table S1 (e.g. RP11-244M2.1 and
RP11-120D5.1 for proliferation, LINC00704 and RP5-
1158E12.3 for migration and RP11-132A1.4, RP11-
20B24.4 and FOXD2-AS1 for possible associations with
MYC) should be validated by means of wet lab experi-
ments. Ideally, these are based on lncRNA perturbation
combined with genotypic or phenotypic read-outs tailored
to the predicted function.
Case studies
To evaluate the performance of decodeRNA in making
highly confident ncRNA function predictions, case studies
for three different ncRNAs—1 miRNA and 2 lncRNAs—
were performed.
The results of the first evaluation are shown in Figure 2
and display the most significant positively correlated gene
sets for the lncRNA HOTAIR in breast cancer. Among
those are several gene sets related to H3K27 methylation
that is induced by HOTAIR through recruitment of PRC2.
In addition, a gene set containing genes down regulated in
non-metastasized breast cancer—and thus up regulated in
metastasized breast cancer—as well as a gene set related to
genes involved in epithelial to mesenchymal transition con-
firms the experimentally validated association between
Figure 4. Circos plot representing significant ESR1 associated gene sets for microRNA hsa-miR-18a-5p in breast and colon cancer (COAD¼ colon
adenocarcinoma, BRCA¼breast cancer).
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HOTAIR and breast cancer metastasis (36,37). When
looking at the list of correlated gene sets for lncRNA
HOTAIR across all datasets, we again observe various
H3K27me3 related gene sets and several gene sets corrobo-
rating the recently identified role of HOTAIR in adipogen-
esis (Figure 3) (38).
As a second example, we looked at the gene sets corre-
lated with miR-18a-5p in both breast and colon cancer.
Since several studies have identified this miRNA to be a
regulator of ESR1 in these cancer types (39–42), we eval-
uated miR-18a-5p functional contexts in the decodeRNA
output. This association was indeed confirmed with three
ESR1 associated gene sets in the resulting gene set
list, all of which ranked in the top 25 for both datasets
(Figure 4).
As a third and final test to evaluate the decodeRNA
functionality, we performed GSEA on a publically avail-
able RNA sequencing dataset obtained upon MALAT1
perturbation in lung cancer (GEO accession number
GSE43830) and determined the overlap of the resulting
gene sets (upon perturbation) with the ones obtained
through decodeRNA for MALAT1 in lung adenocarcin-
oma (LUAD) and lung squamous cell carcinoma (LUSC).
Both for the LUAD and LUSC datasets, gene sets identified
Figure 5. Gene set overlap between the MALAT1 perturbation experiment in lung cancer and decodeRNA output for MALAT1 in A) lung squamous
cell carcinoma (LUSC,) and B) lung adenocarcinoma (LUAD) datasets. The line-graph displays the cumulative distribution of the gene set overlap in
function of the FDR value, while the bars show the position of decodeRNA gene sets in the ranked list of gene sets obtained from the public MALAT1
perturbation dataset.
Page 6 of 8 Database, Vol. 2017, Article ID bax042
by decodeRNA significantly overlapped with those identi-
fied from the MALAT1 perturbation experiment (Fischer
exact test, LUAD: P< 2.2e-16; LUSC: P¼ 0.003042). Of
note, a higher degree of overlap was seen for the most sig-
nificant decodeRNA gene sets, suggesting that the FDR-
values in decodeRNA can be applied to further prioritize
gene sets (Figure 5). In addition, the overrepresentation of
cell cycle-, cancer-, proliferation- and B-MYB-related gene
sets corresponds to the validated MALAT1 functionality
reported in the literature (43–45). This, together with the
results of the HOTAIR and miR-18a-5p case studies,
underscores the ability of decodeRNA in making accurate
predictions over a broad range of ncRNAs and tissues,
helping researchers in providing a functional context for
their ncRNA molecules of interest.
Discussion/conclusion
The current version (1.0) of decodeRNA contains 12 nor-
mal and 29 cancer tissue types representing a total of
10 489 samples. This vast amount of data for both
miRNAs and lncRNAs, with pre-computed functional con-
text information across a wide variety of tissue types, can
guide researchers in setting up wet lab experiments to fur-
ther elucidate the functions of their ncRNAs of interest. As
decodeRNA functional contexts are predictions, experi-
mental validation remains an essential step of the work-
flow. The aim of a functional context is to provide clues on
putative functions and, as such, guide the selection of a
relevant functional readout or model system. In future up-
dates, we plan to add additional datasets and expand cur-
rently available datasets by reanalysis of (raw) level 1
(small) RNA-seq data from TCGA in order to extend the
number ncRNAs. With functional context information for
>3300 ncRNAs in over 40 data sets, decodeRNA could be
a good starting point for future studies on ncRNA
function.
Supplementary data
Supplementary data are available at Database Online.
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